Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

NCT01109485 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Olopatadine hydrochloride ophthalmic solution 0.1%

Sponsor

Alcon Research